National Cancer Institute; Notice of Closed Meetings, 9212-9213 [2017-02252]
Download as PDF
9212
Federal Register / Vol. 82, No. 22 / Friday, February 3, 2017 / Notices
above. Agencies may obtain copies of
the application directly from the
applicant.
m. Individuals desiring to be included
on the Commission’s mailing list should
so indicate by writing to the Secretary
of the Commission.
n. Comments, Protests, or Motions to
Intervene: Anyone may submit
comments, a protest, or a motion to
intervene in accordance with the
requirements of Rules of Practice and
Procedure, 18 CFR 385.210, .211, .214,
respectively. In determining the
appropriate action to take, the
Commission will consider all protests or
other comments filed, but only those
who file a motion to intervene in
accordance with the Commission’s
Rules may become a party to the
proceeding. Any comments, protests, or
motions to intervene must be received
on or before the specified comment date
for the particular application.
o. Filing and Service of Documents:
Any filing must (1) bear in all capital
letters the title ‘‘COMMENTS’’,
‘‘PROTEST’’, or ‘‘MOTION TO
INTERVENE’’ as applicable; (2) set forth
in the heading the name of the applicant
and the project number of the
application to which the filing
responds; (3) furnish the name, address,
and telephone number of the person
commenting, protesting or intervening;
and (4) otherwise comply with the
requirements of 18 CFR 385.2001
through 385.2005. All comments,
motions to intervene, or protests must
set forth their evidentiary basis. Any
filing made by an intervenor must be
accompanied by proof of service on all
persons listed in the service list
prepared by the Commission in this
proceeding, in accordance with 18 CFR
385.2010.
Dated: January 30, 2017.
Kimberly D. Bose,
Secretary.
DEPARTMENT OF ENERGY
Federal Energy Regulatory
Commission
Combined Notice of Filings
asabaliauskas on DSK3SPTVN1PROD with NOTICES
[FR Doc. 2017–02330 Filed 2–2–17; 8:45 am]
BILLING CODE 6717–01–P
ENVIRONMENTAL PROTECTION
AGENCY
Environmental Impact Statements;
Notice of Availability
BILLING CODE 6717–01–P
Take notice that the Commission has
received the following Natural Gas
Pipeline Rate and Refund Report filings:
Filings Instituting Proceedings
Docket Number: PR17–20–000.
Applicants: Atmos Pipeline—Texas.
Description: Tariff filing per
284.123(b), (e)/: Atmos Pipeline—Texas
17:26 Feb 02, 2017
Dated: January 26, 2017.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
(ER–FRL–9031–6)
[FR Doc. 2017–02288 Filed 2–2–17; 8:45 am]
VerDate Sep<11>2014
Revisions to Statement of Operating
Conditions to be effective 12/21/2016;
Filing Type: 980.
Filed Date: 1/23/17.
Accession Number: 201701235002.
Comments/Protests Due: 5 p.m. ET 2/
13/17.
Docket Numbers: RP17–348–000.
Applicants: Algonquin Gas
Transmission, LLC.
Description: § 4(d) Rate Filing:
Negotiated Rate—Bay State release to
BBPC 792857 to be effective 2/1/2017.
Filed Date: 1/25/17.
Accession Number: 20170125–5063.
Comments Due: 5 p.m. ET 2/6/17.
The filings are accessible in the
Commission’s eLibrary system by
clicking on the links or querying the
docket number.
Any person desiring to intervene or
protest in any of the above proceedings
must file in accordance with Rules 211
and 214 of the Commission’s
Regulations (18 CFR 385.211 and
385.214) on or before 5:00 p.m. Eastern
time on the specified comment date.
Protests may be considered, but
intervention is necessary to become a
party to the proceeding.
eFiling is encouraged. More detailed
information relating to filing
requirements, interventions, protests,
service, and qualifying facilities filings
can be found at: https://www.ferc.gov/
docs-filing/efiling/filing-req.pdf. For
other information, call (866) 208–3676
(toll free). For TTY, call (202) 502–8659.
Jkt 241001
Responsible Agency: Office of Federal
Activities, General Information (202)
564–7146 or https://www.epa.gov/nepa.
Weekly receipt of Environmental Impact
Statements (EISs)
Filed 01/23/2017 through 01/27/2017
Pursuant to 40 CFR 1506.9.
Notice: Section 309(a) of the Clean Air
Act requires that EPA make public its
comments on EISs issued by other
Federal agencies. EPA’s comment letters
on EISs are available at: https://
www.epa.gov/compliance/nepa/
eisdata.html.
EIS No. 20170021, Draft, USAF, MD,
Presidential Aircraft Recapitalization
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
Program at Joint Base Andrews-Naval
Air Facility, Comment Period Ends:
03/20/2017, Contact: Jean Reynolds
210–925–4534.
EIS No. 20170022, Final, RUS, PR,
Arecibo Waste-to-Energy and
Resource Recovery Project, Review
Period Ends: 03/06/2017, Contact:
Steven Polacek 202–205–9805.
Dated: January 31, 2017.
Dawn Roberts,
Management Analyst, NEPA Compliance
Division, Office of Federal Activities.
[FR Doc. 2017–02339 Filed 2–2–17; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Multilevel
Interventions in Cancer Care Delivery.
Date: February 22, 2017.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
4W032/034, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Thomas A. Winters, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, 9609 Medical
Center Drive, Room 7W112, Rockville, MD
20892–9750, 240–276–6386, twinters@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI R03/
R21 SEP–1.
Date: March 2–3, 2017.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Jennifer C. Schiltz, Ph.D.,
Scientific Review Officer, Special Review
E:\FR\FM\03FEN1.SGM
03FEN1
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 82, No. 22 / Friday, February 3, 2017 / Notices
Branch, Division of Extramural Activities,
National Cancer Institute, 9609 Medical
Center Drive, Room 7W634, Rockville, MD
20892–9750, 240–276–5864, jennifer.schiltz@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Provocative Question—6.
Date: March 7, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
6W032/034, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Thomas A. Winters, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, 9609 Medical
Center Drive, Room 7W112, Rockville, MD
20892–9750, 240–276–6386, twinters@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Provocative Question—7.
Date: March 8, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7E032, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Thomas A. Winters, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, 9609 Medical
Center Drive, Room 7W112, Rockville, MD
20892–9750, 240–276–6386, twinters@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Provocative Question—8.
Date: March 16, 2017.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W108, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Clifford W. Schweinfest,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, 9609
Medical Center Drive, Room 7W108,
Rockville, MD 20892–9750, 240–276–6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Member
Conflict SEP.
Date: March 16, 2017.
Time: 12:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W238, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Byeong-Chel Lee, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
VerDate Sep<11>2014
17:26 Feb 02, 2017
Jkt 241001
7W238, Rockville, MD 20892–9750, 240–
276–7755, byeong-chel.lee@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Conference
Grant Review (R13).
Date: March 28, 2017.
Time: 1:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W556, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Bratin K. Saha, Ph.D.,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W556, Rockville, MD 20892–9750, 240–
276–6411, sahab@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 30, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–02252 Filed 2–2–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Partnerships for
Countermeasures Against Select Pathogens
(R01).
Date: February 28–March 2, 2017.
Time: 11:00 a.m. to 5:00 p.m.
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
9213
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Lynn Rust, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G42A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5069,
lrust@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 30, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–02246 Filed 2–2–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Patient-Oriented Research Review
Committee.
Date: February 23–24, 2017.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Cambria Suites—Rockville, 1 Helen
Heneghan Way, Rockville, MD 20895.
Contact Person: Stephanie Johnson Webb,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7196, Bethesda, MD 20892, 301–
827–7992, stephanie.webb@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
E:\FR\FM\03FEN1.SGM
03FEN1
Agencies
[Federal Register Volume 82, Number 22 (Friday, February 3, 2017)]
[Notices]
[Pages 9212-9213]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02252]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Multilevel Interventions in Cancer Care Delivery.
Date: February 22, 2017.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 4W032/034, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Thomas A. Winters, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, 9609 Medical Center Drive, Room 7W112,
Rockville, MD 20892-9750, 240-276-6386, twinters@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI R03/R21 SEP-1.
Date: March 2-3, 2017.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Jennifer C. Schiltz, Ph.D., Scientific Review
Officer, Special Review
[[Page 9213]]
Branch, Division of Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room 7W634, Rockville, MD
20892-9750, 240-276-5864, jennifer.schiltz@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Provocative Question--6.
Date: March 7, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 6W032/034, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Thomas A. Winters, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, 9609 Medical Center Drive, Room 7W112,
Rockville, MD 20892-9750, 240-276-6386, twinters@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, NCI Provocative Question--7.
Date: March 8, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7E032, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Thomas A. Winters, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, 9609 Medical Center Drive, Room 7W112,
Rockville, MD 20892-9750, 240-276-6386, twinters@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Provocative Question--8.
Date: March 16, 2017.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W108, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific
Review Officer, Special Review Branch, Division of Extramural
Activities, National Cancer Institute, 9609 Medical Center Drive,
Room 7W108, Rockville, MD 20892-9750, 240-276-6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Member Conflict SEP.
Date: March 16, 2017.
Time: 12:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W238, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W238, Rockville, MD 20892-9750, 240-276-7755,
byeong-chel.lee@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Conference Grant Review (R13).
Date: March 28, 2017.
Time: 1:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W556, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Bratin K. Saha, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W556, Rockville, MD 20892-9750, 240-276-6411,
sahab@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: January 30, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-02252 Filed 2-2-17; 8:45 am]
BILLING CODE 4140-01-P